Orphanet: Simple search
x

Search for a clinical trial

* (*) mandatory field

154 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

GERMANY

Nordrhein-Westfalen
ESSEN

AUSTRIA

STEIERMARK
GRAZ

Recruiting trial
Ongoing trial
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia (Phase II-III) - AT
Medizinische Universität Graz
Klinische Abteilung für pädiatrische Hämato-Onkologie

AUSTRIA

STEIERMARK
GRAZ

AUSTRIA

WIEN
WIEN

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
INTERFANT-06: International treatment protocol for infants under one year with Acute Lymphoblastic or Biphenotypic Leukemia - BE
Hôpital Universitaire des Enfants Reine Fabiola - HUDERF
Service d'hémato-oncologie, d'immunologie et de rhumatologie pédiatrique

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Recruiting trial
Ongoing trial
LBL 2018: International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma - BE
Hôpital Universitaire des Enfants Reine Fabiola - HUDERF
Service d'hémato-oncologie, d'immunologie et de rhumatologie pédiatrique

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

BELGIUM

OOST-VLAANDEREN
GENT

Ongoing trial
Long-Term Follow-up Protocol for Subjects Treated with JCAR015 - BE
Ghent University Hospital - UZ Gent
Dienst Hematologie

FRANCE

AUVERGNE-RHONE-ALPES
LYON

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberCAALL-F01 : A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents (Phase III)
GH Est des HCL - Institut d'Hématologie et d'Oncologie Pédiatrique (IHOPe)
Service d'immuno-hématologie pédiatrique et de transplantation de moelle osseuse

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
GRAALL-2014: Multicenter trial for the treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults (18-59 years) (Phase II/III) - FR
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Service : Centre des Maladies du Sang

GERMANY

Baden-Württemberg
FREIBURG

GERMANY

Baden-Württemberg
HEIDELBERG

Recruiting trial
Ongoing trial
AIEOP-BFM ALL 2017: International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia (phase 3) -DE-
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde III - Pädiatrische Onkologie, Hämatologie, Immunologie und Pneumologie

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
CD3/CD19 Haplo (E410/2007): Multicenter phase II study of Haploidentical Hematopoietic Cell Transplantation with CD3/CD19 depleted Grafts after a reduced intensity conditioning regimen for adult Patients with Acute Leukemia
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin II - Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmologie

GERMANY

Baden-Württemberg
TÜBINGEN

GERMANY

Berlin
BERLIN

Ongoing trial
ALL-REZ BFM 2002: Multicentre Study for Children With Relapsed Acute Lymphoblastic Leukemia
Otto-Heubner-Centrum für Kinder- und Jugendmedizin
Klinik für Pädiatrie mit Schwerpunkt Onkologie und Hämatologie

GERMANY

Hessen
FRANKFURT AM MAIN

Recruiting trial
Ongoing trial
ALL SCT ped FORUM: Allogeneic Stem Cell Transplantation for Children and Adolescents with Acute Lymphoblastic Leukaemia (Phase II/III) - DE
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
Schwerpunkt Stammzelltransplantation und Immunologie

GERMANY

Hessen
FRANKFURT AM MAIN

GERMANY

Niedersachsen
HANNOVER

GERMANY

Nordrhein-Westfalen
ESSEN

GERMANY

Nordrhein-Westfalen
MÜNSTER

Recruiting trial
Ongoing trial
A Phase I/II Safety, Dose Finding and Feasibility Trial of MB-CART19.1 in Patients With Relapsed or Refractory CD19 Positive B Cell Malignancies
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

GERMANY

Nordrhein-Westfalen
MÜNSTER

Recruiting trial
Ongoing trial
LBL 2018: International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma -DE-
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

GERMANY

Schleswig-Holstein
KIEL

Recruiting trial
Ongoing trial
INTERFANT-06: International treatment protocol for infants under one year with Acute Lymphoblastic or Biphenotypic Leukemia
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Klinik für Kinder- und Jugendmedizin I

GERMANY

Schleswig-Holstein
KIEL

GERMANY

Schleswig-Holstein
KIEL

Ongoing trial
ALL-SZT BFM 2003: Allogenic stem cell transplantation in children and adolescents with Acute Lymphoblastic Leukemia (Phase III)
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Klinik für Kinder- und Jugendmedizin I

GERMANY

Schleswig-Holstein
KIEL

Recruiting trial
Ongoing trial
AIEOP-BFM ALL 2017: International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia (phase 3) -DE-
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Klinik für Kinder- und Jugendmedizin I

IRELAND

County Dublin
DUBLIN

Ongoing trial
International Study for Treatment of Standard Risk Childhood Relapsed Acute Lymphoblastic Leukemia (ALL) 2010 (Phase III) - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

IRELAND

County Dublin
DUBLIN

Ongoing trial
LBL 2018: International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma - IE
Our Lady's Children's Hospital
National Oncology/ Bone Marrow Transplant Centre and Haematology Department

ITALY

LAZIO
ROMA

Recruiting trial
Ongoing trial
Young Adult Acute Lymphoid Leukemia (ALL): "Intensification of Pediatric AIEOP LLA-2000 Treatment. Phase II - IT
Sapienza Università di Roma - Dipartimento di Neurologia e Psichiatria
Dipartimento di Biotecnologie Cellulari ed Ematologia

ITALY

LOMBARDIA
MONZA

Ongoing trial
A phase 1/2 study of SKI-606 in Philadelphia chromosome positive leukemias - IT
Azienda Ospedaliera San Gerardo
Unità di Ricerca Clinica

POLAND

Poznan
POZNAN

Ongoing trial
Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia - PL
Szpital Kliniczny im. K. Jonschera
Department of Paediatric Oncology, Hematology and Hematopoietic Stem Cell Transplantation

SPAIN

Cataluña
BADALONA

Recruiting trial
Ongoing trial
PETHEMA LAL-07FRAIL: Treatment Protocol For Acute Lymphoblastic Leukemia Fragile Patients Ph' Negative Over 55 Years - ES
ICO Badalona - Hospital Germans Trias i Pujol
Servicio de Hematología Clínica

SPAIN

Cataluña
BADALONA

Recruiting trial
Ongoing trial
Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)
ICO Badalona - Hospital Germans Trias i Pujol
Servicio de Hematología Clínica

SPAIN

Cataluña
BADALONA

Recruiting trial
Ongoing trial
Protocol Treatment for Acute Lymphoblastic Leukemia Ph '(Bcr / Abl) Positive Patients Aged> 55 Years Old
ICO Badalona - Hospital Germans Trias i Pujol
Servicio de Hematología Clínica

SPAIN

Cataluña
BARCELONA

Ongoing trial
LBL 2018: International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma (Phase III) - ES
Hospital Universitari Vall d'Hebron
Servicio de Oncología y Hematología Pediátricas

SPAIN

Comunidad Valenciana
VALENCIA

Ongoing trial
LBL 2018: International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma (Phase III) - ES
Hospital Clínico Universitario de Valencia
Unidad de oncología, hematología y TPH pediátrico

SPAIN

Comunidad Valenciana
VALENCIA

SPAIN

Comunidad Valenciana
VALENCIA

Ongoing trial
A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib - ES
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación clínica y traslacional en cáncer

SPAIN

Madrid
ADDRESS: NOT PROVIDED - ES

SPAIN

Madrid
MADRID

SWITZERLAND

Suisse Alémanique
ZÜRICH

SWITZERLAND

Suisse Romande
ADDRESS: NOT PROVIDED - CH

SWITZERLAND

Suisse Romande
ADDRESS: NOT PROVIDED - CH

UNITED KINGDOM

Greater London
LONDON

Recruiting trial
Ongoing trial
UKALL14: A randomized trial for adults with newly diagnosed acute lymphoblastic leukaemia (Phase III)
UCL Cancer Institute, University College London
UCL Cancer Institute

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater London
LONDON

Recruiting trial
Ongoing trial
United Kingdom National Randomised Trial for Children and Young Adults with Acute Lymphoblastic Leukaemia and Lymphoma 2011(PHASE III) - UK
University College London Hospitals, NHS Foundation Trust
Haematology and oncology department

UNITED KINGDOM

Greater Manchester
MANCHESTER

Ongoing trial
International Study for Treatment of Standard Risk Childhood Relapsed Acute Lymphoblastic Leukemia (ALL) 2010 (Phase III) - UK
Royal Manchester Children's Hospital
Medicines for Children Research Network: Greater Manchester, Lancashire and South Cumbria

UNITED KINGDOM

Greater Manchester
MANCHESTER

UNITED KINGDOM

Hampshire
SOUTHAMPTON

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Ongoing trial
Long-Term Follow-up Protocol for Subjects Treated with JCAR015 - GB
Institution: Information not provided - US

ITALY

EMILIA ROMAGNA
BOLOGNA

Recruiting trial
Ongoing trial
Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Policlinico S. Orsola-Malpighi - Area S. Orsola
Dipartimento di Ematologia e Scienze Oncologiche

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques Universitaires UCL Saint-Luc
Pneumologie_Oncologie thoracique

Multinational clinical trial(s)

UNITED STATES

California
LOS ANGELES

A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Children's Hospital Los Angeles
Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL)

GERMANY

Hamburg
HAMBURG

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Long-Term Follow-up Protocol for Subjects Treated with JCAR015
Institution: Information not provided - US